
Calvexã®âäŸ¡æ ŒCLVX
çŸåšã®CalvexäŸ¡æ ŒïŒUSDïŒ
æ¬æ¥ã®Calvexã®åžå Žååã«é¢ãã詳现ãªåæ
Calvexã®åžå ŽæŠèŠ
CalvexïŒCLVXïŒã®çŸåšäŸ¡æ Œã¯--ã§ã24æéäŸ¡æ Œå€åã¯-0.00%ã§ããçŸåšã®æäŸ¡ç·é¡ã¯çŽ--ã§ã24æéååŒéã¯--ã§ãã
åžå Žã«ã€ããŠçè§£ã§ãããšããã§ãããããè³Œå ¥ãååŒãå§ããŸãããã1å人以äžã®æå·è³ç£ãŠãŒã¶ãŒãBitgetã§ååŒãè¡ã£ãŠããŸããBitgetã¯ãCalvexã®ãããªæå·è³ç£ã®å¹ åºãååŒæ¹æ³ããµããŒãããŠããŸããããã«ã¯ãè³Œå ¥ã売åŽãçŸç©ååŒãå ç© ååŒããªã³ãã§ãŒã³ååŒãã¹ããŒãã³ã°ãªã©ãå«ãŸããŸããããã«ãæ¥ç屿ã®äœææ°æçãæäŸããŠããŸãïŒ
Bitgetã®ç¡æã¢ã«ãŠã³ãã«ç»é²ããŠãä»ããååŒãå§ããŸãããïŒãªã¹ã¯ã«é¢ããå 責äºé
äžèšã®åæã¯ãBitgetã®ãªã¢ã«ã¿ã€ã ãã£ãŒãããŒã¿ãšãã¯ãã«ã«ææšã«åºã¥ããBitgetãªãµãŒãããŒã ãåéã»ç¢ºèªãããã®ã§ãããããŸã§åèæ å ±ã§ãããæè³ã¢ããã€ã¹ãæ§æãããã®ã§ã¯ãããŸãããæå·è³ç£ã®äŸ¡æ Œã¯éåžžã«å€åããããã§ãããèªèº«ã®ãªã¹ã¯èš±å®¹åºŠãèæ ®ããäžã§ãæè³å€æãè¡ã£ãŠãã ããã
Calvexåžå Žæ å ±
Calvex (CLVX)ã«ã€ããŠ
ã«ã«ããã¯ã¹ããŒã¯ã³ïŒæå·éè²šã®æŽå²ãšããŒãã£ãŒãã£ãŒ
æå·é貚ã¯ããããã³ã€ã³ã®ç»å Žä»¥æ¥ãã€ã³ã¿ãŒãããã®äžéšãšãªããããžã¿ã«ãªéèååŒã®æ°ããªåœ¢ãçã¿åºããŸããããããã®ããžã¿ã«è£œåã¯ãååŒã®èªç±ããšéææ§ãæäŸããã ãã§ãªããåŸæ¥ã®éèåžå Žã§ã¯æäŸã§ããªãã£ãæ°ããªå©çãåŒãåºããŠããŸãã
ãã®äžã§çªåºããŠããã®ããã«ã«ããã¯ã¹ããŒã¯ã³ãªã®ã§ãã
ã«ã«ããã¯ã¹ããŠã¯ã³ã®æŽå²ãšéèŠæ§
ã«ã«ããã¯ã¹ããŒã¯ã³ã¯ããããã¯ãã§ãŒã³æè¡ã®é²æ©ãšå ±ã«æ°ãã«çã¿åºãããæå·é貚ã®äžã€ã§ããããã¯ããããã¯ãã§ãŒã³ãã¯ãããžãŒãæå€§éã«æŽ»çšãããã©ã³ã¶ã¯ã·ã§ã³ã®å®å šæ§ãšé床ãå ŒãåããŠããŸãããã®çµæãã«ã«ããã¯ã¹ããŒã¯ã³ã¯æ¥éã«æ®åããããžã¿ã«é貚åžå Žã«ãããéèŠãªäœçœ®ãå ããããã«ãªããŸããã
ã«ã«ããã¯ã¹ããŠã¯ã³ã®ç¹é·
ã«ã«ããã¯ã¹ããŠã¯ã³ã¯ã以äžã®ãããªç¹é·ãæã£ãŠããŸãã
-
éææ§: å šãŠã®ãã©ã³ã¶ã¯ã·ã§ã³ã¯å ¬éããã誰ã§ãã¢ã¯ã»ã¹ã§ããŸããããã«ããããŠãŒã¶ãŒã¯èªåã®ãéã®åããåžžã«ç¢ºèªã§ããŸãã
-
ã»ãã¥ãªãã£: ææ°ã®æå·åæè¡ã䜿çšããŠããŠãŒã¶ãŒã®è³ç£ãšæ å ±ãä¿è·ããŸããããã«ãããäžæ£ã¢ã¯ã»ã¹ãè©æ¬ºãããŠãŒã¶ãŒãå®ããŸãã
-
é床: ãããã¯ãã§ãŒã³æè¡ã«ããããã©ã³ã¶ã¯ã·ã§ã³ã¯ç§åäœã§åŠçãããŸããããã«ãããäŒçµ±çãªéè¡ã®ãããªæéå¶éãé å»¶ãæ°ã«ããããšãªãããã€ã§ãã©ãã§ãååŒãå¯èœã§ãã
-
å©äŸ¿æ§: ã«ã«ããã¯ã¹ããŠã¯ã³ã¯ãã¹ããŒããã©ã³ãããœã³ã³ããçŽæ¥ã¢ã¯ã»ã¹ã§ããŸããããã«ããããŠãŒã¶ãŒã¯èªç±ã«ããããŠç°¡åã«ååŒãè¡ãããšãã§ããŸãã
ãããã®ç¹é·ã«ãããã«ã«ããã¯ã¹ããŠã¯ã³ã¯ä»ã®æå·é貚ãšã¯äžç·ãç»ãååšãšãªã£ãŠããŸãããããããã«ã«ããã¯ã¹ããŠã¯ã³ã¯ãããã¯ãã§ãŒã³æè¡ã®é²æ©ãšãšãã«ãé²åãç¶ããã§ãããã
CalvexïŒCLVXïŒãªã©ã®æå·è³ç£ãè³Œå ¥ããã®ã«æé©ãªå Žæã¯ïŒ
Calvexã®äŸ¡æ Œäºæž¬
2027幎ã®CLVXã®äŸ¡æ Œã¯ã©ããªãïŒ
+5%ã®å¹Žéæé·çã«åºã¥ããšãCalvexïŒCLVXïŒã®äŸ¡æ Œã¯2027幎ã«ã¯$0.00ã«éãããšäºæ³ãããŸããä»å¹Žã®äºæ³äŸ¡æ Œã«åºã¥ããšãCalvexãæè³ããŠä¿æããå Žåã®çŽ¯ç©æè³åççã¯ã2027幎æ«ã«ã¯+5%ã«éãããšäºæ³ãããŸãã詳现ã«ã€ããŠã¯ã2026幎ã2027幎ã2030ã2050幎ã®CalvexäŸ¡æ Œäºæž¬ãã芧ãã ããã2030幎ã®CLVXã®äŸ¡æ Œã¯ã©ããªãïŒ
âæ³šç®ã®ãã£ã³ããŒã³
Calvex(CLVX)ã®è³Œå ¥æ¹æ³

ç¡æã§Bitgetã¢ã«ãŠã³ããäœæããŸã

ã¢ã«ãŠã³ããèªèšŒãã

CLVXãUSDã«äº€æ
ããããã質å
Calvexã®çŸåšã®äŸ¡æ Œã¯ãããã§ããïŒ
Calvexã®24æéååŒéã¯ïŒ
Calvexã®é廿é«å€ã¯ãããã§ããïŒ
Bitgetã§Calvexãè³Œå ¥ã§ããŸããïŒ
Calvexã«æè³ããŠå®å®ããåå ¥ãåŸãããšã¯ã§ããŸããïŒ
Calvexãæãå®ãè³Œå ¥ã§ããã®ã¯ã©ãã§ããïŒ
仿¥ã®æå·è³ç£äŸ¡æ Œ
CalvexïŒCLVXïŒã¯ã©ãã§è²·ããŸããïŒ
åç»ã»ã¯ã·ã§ã³ - çŽ æ©ãèªèšŒãçµããŠãçŽ æ©ãååŒãž
CLVXã®åçš®è³æ
ã¿ã°ïŒ
